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SUMMARY
A postal questionnaire was sent to all gynaecological consultants and senior
registrars (n = 50) in Northern Ireland to establish the prevalence ofprophylactic
oophorectomy. Forty three (84%) replied. 72% performed prophylactic
oophorectomy (28% unilateral), 28% did not. With reference to the world
literature, there appears to be no benefit from the unilateral procedure but a
consensus that bilateral oophorectomy is an option which should be considered
in certain cases where there is a high risk of ovarian cancer.
INTRODUCTION
Each year in Northern Ireland there are 150 new cases of ovarian carcinoma.'
This is the fifth commonest cause of cancer-related death in Northern Ireland,
with approximately 90 deaths per year. Ovarian carcinoma is responsible for
4-5 % of deaths in females below the age of 60,2 and the death rate from
ovarian carcinoma exceeds that of the cervix and the uterine corpus combined.
This cancer presents late, in less than 30% of cases being confined to the ovaries
at the time of diagnosis. Unlike the cervix and breast, the ovary is a hidden
organ which does not lend itself to simple examination, so late presentation with
advanced disease and poor prognosis is the rule. Early diagnosis can be improved
by screening all women, or at-risk populations. Cervical smears and clinical
pelvic examination are insensitive screening investigations. Tumour markers such
as Ca -125 could provide a useful screening technique but have not yet been
proved to be effective.3 Abdominal ultrasound4, 5 and transvaginal colour flow
imaging6 are being evaluated and may prove to be effective screening tools in
the future.
Traditional treatments are at best poor, with a five year survival of less than 25 %
and newer therapies such as monoclonal antibody directed chemotherapy and
radiotherapy are still largely experimental. For many years it has been suggested
that the incidence of ovarian cancer could be reduced if prophylactic
oophorectomy wasperformed on women undergoing pelvic surgery. Manyfactors
must be considered including the patient's age, menopausal status, presence of
carcinogenic risk factors and contraindications to hormone replacement therapy.
The procedure of prophylactic oophorectomy is therefore a delicate balance
between the risk of developing ovarian cancer and the consequences of removing
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normal ovaries. This study was undertaken to establish the current practice of
prophylactic oophorectomy in Northern Ireland.
METHODS
In Northern Ireland there are seventeen hospitals which perform gynaecological
surgery. A postal questionnaire was sent to all consultant gynaecologists (n = 42)
and gynaecological senior registrars (n = 8). In order to encourage the response
rate, replies were anonymous and postage was prepaid. This study was carried
out during a six week period of 1988.
RESULTS
Forty three (84%) replies were received and the results are summarised in the
Table. Prophylactic oophorectomy during hysterectomy was performed at some
time by up to 72% of gynaecologists. Their practice was dependent on the
patient's age and menopausal status, with a natural transition appearing between
the ages of 40 and 45. Unilateral prophylactic oophorectomy was carried out by
28% of the sample and was generally performed when the patient was aged
between 40 and 45 years.
A second group of sufgeons (26%) never removed normal ovaries as a prophy-
lactic procedure during hysterectomy.
If prophylactic oophorectomy was performed before the menopause 12 (57%)
prescribed hormone replacement therapy, whereas 7 (33%) prescribed this only
ifthepatient became symptomatic. Twosurgeons (10%) used oestradiol implants
at the time of surgery.
TABLE
Prophylactic oophorectomy questionnaire: (43 replies from 50 gynaecologists
circulated in Northern Ireland)
Question Answer - yes
n %
Bilateral prophylactic oophorectomy?
Post.menopausal 31 72%
Pre
-menopausal
Age>50 20 48%
Age>45 12 28%
Age >40 2 5%
Age.<40 0
Never remove normal ovaries? 12 28%
Unilateral prophylactic oophorectomy? 12 28%
DISCUSSION
One of the most frequent yet still controversial decisions to be made when
performing a hysterectomy is whether to remove or retain the normal ovaries.
This decision is often made using subjective prejudices, perhaps during the
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surgical procedure itself. From this study it appears that there is wide variation in
attitudes to prophylactic oophorectomy, a finding which is not unique to Northern
Ireland.7 A review of the literature indicates that the need for prophylactic
oophorectomy has been questioned many times, with no clear answer.8
How many patients with retained ovaries actually develop carcinoma of the
ovary? Jacobs and Oram9 recently reviewed twelve studies in which the average
incidence of cancer in retained ovaries, after surgery for benign gynaecological
disease, was 0-2%. This seems a very small and quite acceptable figure.
However, all of these studies suffer from the fact that long term (greater than 10
years) follow-up is difficult due to population mobility, and a woman may die
from an unrelated disease and an ovarian tumour remain undiscovered. The
second approach is to examine how many patients with ovarian carcinoma have
undergone previous pelvic surgery where prophylactic oophorectomy could have
been performed. Studies of this question give figures ranging from 4-5% 10 to
14%," an average figure from twelve studies is 10%.
In practical terms, if prophylactic oophorectomy were performed as a routine at
pelvic surgery approximately 400 lives would be saved in England and Wales,
where over 4000 women die each year, and at least nine peryearwould be saved
in Northern Ireland. Prophylactic oophorectomy would also eradicate benign
ovarian disease, pain from residual ovarian syndrome and would reduce the
morbidity associated with further surgery.'2
If functioning ovarian tissue is removed, then hormone replacement therapy is
indicated. Premature removal of ovarian steroids may or may not be adequately
replaced by current replacement therapy, but ifthere are no contraindications it is
now largely accepted that the psychological, cardiovascular and musculoskeletal
benefits of such therapy outweigh the risks.'3 The ovarian stroma retains some
function after the menopause but there is only a small endocrine contribution.
Prophylactic removal ofpost*menopausal ovaries should therefore not cause any
endocrine problems as most post-menopausal oestrogen comes from peripheral
conversion of adrenal androgen.
The aetiology of ovarian cancer remains unknown but it occurs in association
with an early menarche, late menopause, previous mumps infection and pelvic
irradiation. One of the most convincing theories was postulated in 1972 by
Fathallah14 who suggested that the trauma of incessant ovulation may predispose
to the development of cancer. Ovulation suppression by pregnancy, lactation and
oral contraceptive use may therefore be protective, but the prophylactic removal
ofjust one ovary in the pre
-menopausal woman would lead to a relative increase
in ovulation in the remaining ovary which might possibly increase the neoplastic
risk.15
Opponents of prophylactic oophorectomy suggest that, using these arguments,
general surgeons should perform prophylactic mastectomy to reduce breast
carcinoma and remove testicles at the time of inguinal hernia repair. In reply, it
should be remembered that the ovary is a hidden organ, in which cancer is more
comparable to that of the pancreas than to cancer of the breast or testis.
In the absence of better diagnostic and therapeutic procedures for ovarian
disorders, I would suggest that prophylactic oophorectomy be used to reduce
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both benign and malignant ovarian disease. It should be considered by all those
operating in the female pelvis and should be planned prior to surgery with
the patient partaking in the decision-making process. Current gynaecological
practice in Northern Ireland shows that a majority of surgeons consider that
ovaries should be removed during any pelvic surgery after the menopause
and that in the pre-menopausal patient over the age of 40, prophylactic
oophorectomy is an option which must be considered, especially if there is a
strong family history of ovarian cancer or there are other high-risk features.
Regarding the practice of unilateral prophylactic oophorectomy, review of the
literature reveals no benefit from performing such a procedure and in theory it
may even be detrimental.
I would like to thank the members ofthe Ulster Obstetrical and Gynaecological Society fortheir help in
this study.
REFERENCES
1. Gavin A. A handbook of cancer in Northern Ireland. Belfast: Ulster Cancer Foundation, 1989:
7-11.
2. Cramer DW. Epidemiologic and statistical aspects of gynecologic oncology. In: Knapp RC,
Berkowitz RS, eds. Gynecologic Oncology. New York: Macmillan, 1985: 210-22.
3. Zurawski VR, Orjaseter H, Andersen A, Jellum E. Elevated serum Ca-125 levels prior to
diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer. Int J Cancer
1988; 42: 677-80.
4. Campbell S, Bhan V, Royston P, Whitehead Ml, Collins WP. Transabdominal ultrasound
screening for early ovarian cancer. Br Med J 1989; 299: 1363 7.
5. Andolf E, Svalenius E, Astedt B. Ultrasonography for early detection of ovarian carcinoma.
Br J Obstet Gynaecol 1986; 93: 1286 -9.
6. Bourne T, Campbell S, Steer C, Whitehead Ml, Collins WP. Transvaginal colour flow imaging:
a possible new screening technique for ovarian cancer. Br Med J 1989; 299: 1367-70.
7. Jacobs I, Oram D. Prevention of ovarian cancer: a survey of the practice of prophylactic
oophorectomybyfellowsand membersoftheRoyal College ofObstetricians and Gynaecologists.
Br J Obstet Gynaecol 1989; 96: 510 -5.
8. Jacobs I, Oram D. Prophylactic oophorectomy. Br J Hosp Med 1987; 38: 440 -9.
9. Jacobs I, Oram D. Improving the prognosis in ovarian cancer. In: Studd J, ed. Progress in
Obstetrics and Gynaecology (Vol 6). Edinburgh: Churchill Livingstone, 1987: 339-432.
10. Counsellor VS, Hunt W, Haigler FH. Carcinoma of the ovary following hysterectomy. Am J
Obstet Gynecol 1955; 69: 538-46.
11. McGowan L. Ovarian cancer after hysterectomy. Obstet Gynecol 1987; 69: 386-9.
12. Christ JE, Lotze EC. The residual ovary syndrome. Obstet Gynecol 1975; 46: 551-6.
13. Studd JWW, Whitehead Ml. The menopause. Oxford: Blackwell Scientific Publications, 1988.
14. Fathalla MF. Factors in the causation and incidence of ovarian cancer. Obstet Gynecol Surv
1972; 27: 751-68.
15. Randall CL, Hall DW, Armenia CS. Pathology in the preserved ovary after unilateral
oophorectomy. Am J Obstet Gynecol 1962; 84: 1233-41.
@O The Ulster Medical Society, 1991.